Dark Forest Capital Management LP Revolution Medicines, Inc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $469,725 - $625,374	23,162 New	23,162 $619,000
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $41,118 - $61,230	2,355 Added 2646.07%	2,444 $48,000
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $425,498 - $795,102	-29,264 Reduced 99.7%	89 $2,000
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $489,422 - $746,433	28,274 Added 2620.39%	29,353 $749,000
Q4 2021 Feb 11, 2022	BUY	$24.35 - $33.7 $26,273 - $36,362	1,079 New	1,079 $27,000
Q3 2021 Nov 12, 2021	SELL	$23.95 - $33.41 $1,125 - $1,570	-47 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $1,363 - $2,229	47 New	47 $1,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.